Yahoo Finance • 2 months ago
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights b... Full story
Yahoo Finance • 2 months ago
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the... Full story
Yahoo Finance • 3 months ago
We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best NASDAQ stocks under $5. Job Market Cools Yet Economists Remain Optimistic About Stab... Full story
Yahoo Finance • 7 months ago
Shares of Geron(NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was reacting to news the company's investors had been waiting to hear for decades. On June 6, the U.S. Food and Drug Administration (FDA) approved G... Full story
Yahoo Finance • 9 months ago
Geron Corp (NASDAQ:GERN) shares are soaring in Thursday's after-hours session after the company announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted in favor of the clinical benefit/r... Full story
Yahoo Finance • last year
Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS FOSTER CITY, Calif., December 04, 2023--(BUSINESS WIRE)--Geron Corporation (Nasdaq:... Full story
Yahoo Finance • last year
Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript November 2, 2023 Geron Corporation beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.1. Operator: Good morning. My name is Audrey, and I will be yo... Full story
Yahoo Finance • 2 years ago
Geron Corporation (NASDAQ: GERN) submitted a marketing application with the FDA seeking approval for imetelstat for the treatment of transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes... Full story
Yahoo Finance • 2 years ago
Participants Anil Kapur; Executive VP of Corporate Strategy & Chief Commercial Officer; Geron Corporation Aron Feingold; VP of IR & Corporate Communications; Geron Corporation Faye Feller; Executive VP & Chief Medical Officer; Geron Cor... Full story
Yahoo Finance • 2 years ago
In this article, we discuss the 10 hot healthcare stocks to buy now. If you want to read about some more hot healthcare stocks to buy now, go directly to 5 Hot Healthcare Stocks To Buy Now. The rise of consumer prices has often lagged beh... Full story
Yahoo Finance • 2 years ago
Leadership in place for core commercial functions, including in Market Access, Trade & Channel Relations, Commercial Operations, Analytics, Marketing, Sales and Medical Affairs Company continues stage-gated commercial readiness efforts for... Full story
Yahoo Finance • 2 years ago
In this article, we discuss 10 rebounding small cap stocks to buy now. If you want to see the top stocks in this category, check out 5 Rebounding Small-Cap Stocks to Buy Now. Carter Worth, the CEO of Worth Charting, joined CNBC’s ‘The Exc... Full story
Yahoo Finance • 3 years ago
FOSTER CITY, Calif., April 01, 2022--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 53,333,334 sha... Full story